The Supreme Court will hear a landmark patent case alleging a drug maker sought to keep low-cost generic versions of a popular hypertension medication off the market. Justices agreed to hear an appeal in the dispute that saw generic manufacturer Apotex Inc. sue for lost profits: “It’s the fault of Parliament for creating this insane system”.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
